Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a new publication citation: Avapritinib improves cutaneous involvement in indolent systemic mastocytosis from the PIONEER study (J Am Acad Dermatol, online ahead of print).
    Difference
    0.0%
    Check dated 2026-02-21T17:02:40.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    New revision tag updated from v3.4.1 to v3.4.2; no other content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T13:20:29.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    - Revision: v3.4.1 replaces v3.4.0 on the page.
    Difference
    0.0%
    Check dated 2026-02-07T08:27:42.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Added a glossary display and updated metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0). Some labels were removed or changed (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-24T02:52:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page shows a new Revision tag: v3.3.4 replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:53:27.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites across US states and Canadian provinces. Removed the HHS Vulnerability Disclosure notice and updated the revision tag to v3.3.3.
    Difference
    1%
    Check dated 2025-12-19T10:23:43.000Z thumbnail image

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.